HSBC HOLDINGS PLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$10,185,477
+59.2%
112,112
+49.9%
0.01%
+66.7%
Q2 2023$6,397,842
-28.3%
74,771
-30.9%
0.01%
-40.0%
Q1 2023$8,922,786
-17.6%
108,155
-22.3%
0.01%
-16.7%
Q4 2022$10,829,896
+156.8%
139,152
+147.2%
0.01%
+71.4%
Q3 2022$4,217,000
+46.6%
56,283
+29.0%
0.01%
+75.0%
Q2 2022$2,877,000
+0.7%
43,622
-3.7%
0.00%
+33.3%
Q1 2022$2,857,000
+76.8%
45,295
+50.3%
0.00%
+200.0%
Q4 2021$1,616,000
-76.7%
30,135
-69.3%
0.00%
-85.7%
Q3 2021$6,939,000
+10.5%
98,261
+4.1%
0.01%0.0%
Q2 2021$6,281,000
+699.1%
94,436
+1239.9%
0.01%
+600.0%
Q1 2021$786,000
+129.8%
7,048
+143.6%
0.00%
Q4 2020$342,000
-52.4%
2,893
-53.7%
0.00%
-100.0%
Q4 2019$718,000
-12.4%
6,249
-3.8%
0.00%
-50.0%
Q3 2019$820,000
+60.5%
6,494
+52.9%
0.00%
+100.0%
Q2 2019$511,000
+22.2%
4,246
-11.2%
0.00%0.0%
Q1 2019$418,000
+67.9%
4,781
+92.1%
0.00%
Q4 2018$249,000
-14.7%
2,489
-2.3%
0.00%
Q3 2018$292,000
-98.7%
2,547
-99.0%
0.00%
-100.0%
Q2 2018$22,814,000
+249.6%
254,397
+185.3%
0.04%
+310.0%
Q1 2018$6,525,000
+1366.3%
89,175
+704.8%
0.01%
+900.0%
Q4 2016$445,00011,0810.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders